About UsProductsCareersInvestorsContact UsSearch
Nabi Biopharmaceuticals
Powering the Immune System
INVESTORS
Investor Overview
News Releases
Events and Webcasts
Stock Information
Earnings Estimates
Analyst Coverage
Annual Reports
Proxy Online
Email Alerts
SEC Filings
Advanced
Fundamentals
Investor FAQ
Information
Requests
Corporate
Governance
 
News Releases
Keyword Search
 
2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004
11/09/12Nabi Biopharmaceuticals Effects Reverse Stock Split and Announces the Completion of and Final Exchange Ratio for the Business Combination Transaction With Biota Holdings LimitedPrinter Friendly Version
11/08/12Nabi Biopharmaceuticals Announces Third Quarter 2012 Financial ResultsPrinter Friendly Version
11/05/12Nabi Biopharmaceuticals Announces Special Cash DividendPrinter Friendly Version
10/25/12The Board of Nabi Biopharmaceuticals Establishes Ratio for Reverse Stock SplitPrinter Friendly Version
10/23/12Nabi Biopharmaceuticals Announces Nabi Stockholder Meeting Results and the Approval of the Business Combination Transaction by Biota StockholdersPrinter Friendly Version
10/19/12Nabi Biopharmaceuticals Announces Exchange Ratio for Proposed Business Combination Transaction With Biota Holdings LimitedPrinter Friendly Version
10/17/12Nabi Biopharmaceuticals Announces Results of NicVAX(R) Phase II Study in Combination With VareniclinePrinter Friendly Version
10/16/12Two Major Independent Proxy Advisory Firms Recommend Nabi Biopharmaceutical Stockholders Support Amended Transaction With Biota Holdings Limited at October 22nd Reconvened Special MeetingPrinter Friendly Version
10/16/12Nabi Biopharmaceuticals Sets Record Date for Cash DividendPrinter Friendly Version
09/24/12Nabi Biopharmaceuticals Announces Adjournment of Special Meeting of Stockholders Until October 22, 2012Printer Friendly Version
09/17/12Nabi Biopharmaceuticals and Biota Holdings Limited Amend Terms of Business Combination; Mangrove Partners Agrees to Support the Amended TransactionPrinter Friendly Version
09/06/12Biota in Advanced Discussions With Russell H. Plumb to Assume Role of President and CEO of Biota Pharmaceuticals, Inc.Printer Friendly Version
08/23/12Nabi Sends Letter to Stockholders Responding to Mangrove's Statements and Calls on Stockholders to Vote Their White Proxy Card TodayPrinter Friendly Version
08/09/12Nabi Biopharmaceuticals Announces Second Quarter 2012 Financial ResultsPrinter Friendly Version
08/02/12Nabi Biopharmaceuticals Announces Final Results of Its Self-Tender OfferPrinter Friendly Version
08/02/12Nabi Biopharmaceuticals Announces Second Quarter 2012 Financial Results Release DatePrinter Friendly Version
07/31/12Nabi Biopharmaceuticals Announces Preliminary Results of Its Self-Tender OfferPrinter Friendly Version
07/19/12Nabi Biopharmaceuticals Announces Waiver of Cash Reserve Tender Offer ConditionPrinter Friendly Version
07/02/12Nabi Biopharmaceuticals Announces Commencement of Self-Tender Offer for Up To $23,000,000 of Its Common StockPrinter Friendly Version
05/10/12Nabi Biopharmaceuticals Announces First Quarter 2012 Financial ResultsPrinter Friendly Version
05/03/12Nabi Biopharmaceuticals Announces First Quarter 2012 Financial Results Release DatePrinter Friendly Version
04/23/12Nabi Biopharmaceuticals Announces Definitive Merger Agreement With Biota Holdings LimitedPrinter Friendly Version
03/14/12Nabi Biopharmaceuticals Announces Fourth Quarter and Full-Year 2011 Financial ResultsPrinter Friendly Version
03/07/12Nabi Biopharmaceuticals to Announce 2011 Fourth Quarter and Year-End Financial Results on March 14, 2012Printer Friendly Version
^ Top

© 2010 Nabi Biopharmaceuticals   |   Site Map    |   Glossary of Terms    |   Terms and Conditions of Use